| Ms Christine Flaugh, | |
|
1100 W Main St, Norristown, PA 19401-4331 | |
| (610) 292-9960 | |
| Not Available |
| Full Name | Ms Christine Flaugh |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1100 W Main St, Norristown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134400427 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH04780 (Rhode Island) | Secondary |
| 183500000X | Pharmacist | RP438448 (Pennsylvania) | Primary |
| 183500000X | Pharmacist | S011258 (Arizona) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Christine Flaugh, 1100 W Main St, Norristown, PA 19401-4331 Ph: (610) 292-9960 | Ms Christine Flaugh, 1100 W Main St, Norristown, PA 19401-4331 Ph: (610) 292-9960 |
News Archive
Robotic surgical technology with its three-dimensional, high-definition view gives surgeons the sensation of touch, even as they operate from a remote console. A new study describes the phenomenon, called intersensory integration, and reports that surgical outcomes for prostate cancer surgery using minimally invasive robotic technology compare favorably with traditional invasive surgery.
Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer's disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging.
End-of-life care has become a target for critics who allege many hospitals and physicians order unnecessary and expensive procedures, but it often involves difficult and complex decision-making. The New York Times reports on one hospital with large end-of-life care bills:
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
The prevalence of prescription opioid use increased from 4.1% of US adults in 1999-2000 to 6.8% in 2013-2014, according to a recent Pharmacoepidemiology and Drug Safety study.
› Verified 1 days ago
John Taek Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 699 W Germantown Pike, Norristown, PA 19403 Phone: 610-630-5819 | |
Kathryn Ching, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 80 W Germantown Pike, Norristown, PA 19401 Phone: 610-279-6575 | |
Paul Cianfichi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Sterigere St, Norristown, PA 19401 Phone: 610-313-5864 | |
Vimala An, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25 W Germantown Pike, Norristown, PA 19401 Phone: 610-278-0256 Fax: 610-278-4821 | |
Mr. David Lee, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2550 Eisenhower Ave, Norristown, PA 19403 Phone: 484-690-0160 | |
Daniel Desch, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 Boulevard Of The Generals, Norristown, PA 19403 Phone: 610-539-5093 | |
Dr. Nick Regis Mastrine, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 Boulevard Of The Generals, Norristown, PA 19403 Phone: 610-539-5093 Fax: 610-539-5294 |